{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:50:53Z","timestamp":1760057453776,"version":"build-2065373602"},"reference-count":24,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Standard Improvement Project \u201cDetermination of residual protein in cell matrix\u201d in China"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: Host cell proteins (HCPs) from primary hamster kidney cells (PHKCs) used to produce rabies vaccines may cause an allergic reaction in humans, so these residual HCPs must be controlled. Establishing a national standard for PHKC HCP is very important to ensure the consistency of HCPs between batches of the vaccine and to standardize the control of HCPs. Objectives: We aimed to establish a novel national standard substance to determine the HCP residue in rabies vaccines produced with PHKCs. Methods: A two-step multi-laboratory collaborative collaboration was undertaken. In the first step, the protein concentration of the standard substance stock solution was determined using Lowry\u2019s method. In the second step, the concentration of the candidate standard substance was determined with an enzyme-linked immunosorbent assay. Results: The concentration of the PHKC protein standard was 4.0 \u03bcg\/mL (95% confidence interval: 3.5\u20134.4 \u03bcg\/mL). Conclusions: The PHKC protein standard was approved by the Chinese National Committee on Standards for the quality control of PHKC-based rabies vaccines for human use, and it plays an important role in controlling the quality of these human vaccines.<\/jats:p>","DOI":"10.3390\/vaccines13020180","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T05:10:22Z","timestamp":1739423422000},"page":"180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Novel Standard Substance from Primary Hamster Kidney Cells for Quality Control of Human Rabies Vaccines in China"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9713-8855","authenticated-orcid":false,"given":"Leitai","family":"Shi","sequence":"first","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1167-5439","authenticated-orcid":false,"given":"Jia","family":"Li","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6471-1285","authenticated-orcid":false,"given":"Xiaohong","family":"Wu","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouchun","family":"Cao","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunpeng","family":"Wang","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhua","family":"Zhao","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-8046","authenticated-orcid":false,"given":"Yuhua","family":"Li","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"ref_1","unstructured":"WHO (2024, June 05). Rabies. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rabies."},{"key":"ref_2","unstructured":"Stanley, A.P., Walter, A.O., Paul, A.O., and Kathryn, M.E. (2018). Vaccines, Elsevier. [7th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3181\/00379727-98-23997","article-title":"Growth of rabies virus in non-nervous tissue culture","volume":"98","author":"Kissling","year":"1958","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4049\/jimmunol.91.3.362","article-title":"Anti-rabies vaccine of tissue culture origin","volume":"91","author":"Kissling","year":"1963","journal-title":"J. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1139\/m60-072","article-title":"A rabies vaccine from hamster kidney tissue cultures: Preparation and evaluation in animals","volume":"6","author":"Fenje","year":"1960","journal-title":"Can. J. Microbiol."},{"key":"ref_6","first-page":"65","article-title":"RAdaptation and biological characteristics of rabies virus \u201cBeijing strain\u201d in hamster kidney cell culture","volume":"2","author":"Lin","year":"1982","journal-title":"Acta Virolog. Sin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/infdis\/147.3.467","article-title":"The primary hamster kidney cell rabies vaccine: Adaptation of viral strain, production of vaccine, and pre- and postexposure treatment","volume":"147","author":"Lin","year":"1983","journal-title":"J. Infect. Dis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S766","DOI":"10.1093\/clinids\/10.Supplement_4.S766","article-title":"Use of serum and vaccine in combination for prophylaxis following exposure to rabies","volume":"10","author":"Lin","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"ref_9","unstructured":"WHO (1991). Expert Committee on Rabies, World Health Organization. 8th Report."},{"key":"ref_10","first-page":"338","article-title":"Progress in research on application of rabies virus aG strain in rabies vaccine for human use","volume":"35","author":"Shi","year":"2022","journal-title":"Chin. J. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00216-021-03648-2","article-title":"Monitoring process-related impurities in biologics\u2013host cell protein analysis","volume":"414","author":"Katrine","year":"2022","journal-title":"Anal Bioanal Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4161\/bioe.23382","article-title":"Host cell protein dynamics in recombinant CHO cells: Impacts from harvest to purification and beyond","volume":"4","author":"Hogwood","year":"2013","journal-title":"Bioengineered"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/btpr.2640","article-title":"Experience with host cell protein impurities in biopharmaceuticals","volume":"34","author":"Vanderlaan","year":"2018","journal-title":"Biotechnol. Prog."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/bit.25327","article-title":"Host cell protein testing by ELISAs and the use of orthogonal methods","volume":"111","author":"Zhu","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"ref_15","unstructured":"Chinese Pharmacopoeia Commission (2020). Pharmacopoeia of the People\u2019s Republic of China, Chinese Pharmacopoeia Commission."},{"key":"ref_16","unstructured":"National Administrative Committee for CRM\u2019s (2010). Development Management and Application of Reference Materials, China Metrology Publishing House. [1st ed.]."},{"key":"ref_17","unstructured":"National Administrative Committee for CRM\u2019s (2011). Principles of Reference Material Value and Statistics, China Quality Inspection Press. [1st ed.]."},{"key":"ref_18","unstructured":"WHO (2018). Expert Consultation on Rabies, World Health Organization. 3rd Report."},{"key":"ref_19","unstructured":"National Institutes for Food and Drug Control (2024, November 30). Announcement of Lot Release of Biological Products. Available online: https:\/\/www.nifdc.org.cn\/nifdc\/xxgk\/ggtzh\/jwgk\/shwzhppfgg\/index.html."},{"key":"ref_20","first-page":"48","article-title":"Study on immunogenicity of rabies vaccine (primary hamster kidney cell)","volume":"6","author":"Wu","year":"2023","journal-title":"Prog. Microbiol. Immunol."},{"key":"ref_21","unstructured":"WHO (1998). Expert Committee on Biological Standardization, World Health Organization. 47th Report; Requirements for the use of animal cells as in vitro substrates for the production of biological. Annex 1."},{"key":"ref_22","unstructured":"WHO (2013). Expert Committee on Biological Standardization, World Health Organization. 61st Report; Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. Annex 3."},{"key":"ref_23","first-page":"9","article-title":"Establishment and initial validation of an ELISA method for determination of host cell protein in PHKC vaccines","volume":"33","author":"Zhao","year":"2010","journal-title":"Int. J. Biol."},{"key":"ref_24","first-page":"175","article-title":"Residual host cell proteins and their detection methods in biological products","volume":"41","author":"Fan","year":"2018","journal-title":"Int. J. Biol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/2\/180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:32:51Z","timestamp":1760027571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/2\/180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["vaccines13020180"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13020180","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2025,2,13]]}}}